Thailand’s Ambassador to Pakistan, Rongvudhi Virabutr, recently met with senior business leaders at the Lahore Chamber of Commerce and Industry (LCCI) to call for a strengthening of economic links — particularly in the pharmaceutical sector. In the meeting, both sides agreed that medicine manufacturing and trade present a powerful shared opportunity.

The LCCI leadership noted that Pakistan already exports “medicaments” to Thailand and expressed optimism about opening up further. The Chamber believes that a modern free trade agreement (FTA) could unlock growth by creating better terms for pharmaceutical products and encouraging Thai investment in Pakistan’s drug industry.

With Thailand’s strong industrial base and Pakistan’s fast-growing pharma export momentum, collaboration could benefit both countries. Pakistan’s pharmaceutical exports have surged recently, signaling its growing capacity to produce for international markets. Local medicine makers could leverage Thai manufacturing know-how, supply chains, and quality certifications to scale up.

On the Thai side, investment in Pakistan’s pharma industry could open access to new markets and help them engage in a rapidly expanding healthcare economy. The ambassador stressed that the FTA should not just cover goods but also investment flows, enabling pharmaceutical makers to set up joint ventures, R&D units or production facilities.

Business leaders at LCCI suggested regular trade missions, pharma-industry exchanges, and participation in bi-national trade fairs. They believe this will help companies from both sides find synergy in drug manufacturing, generics export and health-tech innovation.

Overall, the meeting was a clear signal: Thailand and Pakistan see pharmaceutical cooperation as a promising piece of their future trade relationship. With the right policies, investment incentives, and supportive frameworks, this could become a cornerstone of regional economic growth in health and pharma.